SCLL - This Stock Is Poised For A Big Run Off Its Recent Bottom

Penny stock traders are always on the look-out for a stock that has fallen so far that it is well over due for a bounce.  These type of stocks almost always rebound sharply posting 100's of % worth of gains.  One such stock soared 200%+ after hitting a bottom yesterday, BANI.  It seems no matter how out of favor a stock is, at some point investors come back knowing that these bottom plays can be highly lucrative.

SCLL just hit its all time low and looks to be starting what I think will be an impressive run off its bottom.  This stock has fallen in a slow steady decline from $.01 down to $.0003 today with nary a bounce.  I think that bounce is coming and it will be impressive to behold.

SCLL is not a shell stock.  The company issued positive news a few months back and has kept investors informed of their current progress.

Just look at what this $.0004 stock has going for it:

Our human embryonic germ cell technology has matured substantially. This work was significantly more difficult than originally anticipated but has resulted in a series of interesting and useful observations that will fill in several missing pieces in human stem cell biology. These observations are currently being finalized and assembled into a form suitable for publication in scientific journals. We anticipate the publication of several such scientific papers over the coming year and these advances will enable us to pursue the application of our technology to drug discovery, liver disease and cancer. It is important to note that this technology is completely separate from standard human embryonic stem cells and comprises a unique and valuable intellectual property. 

You are looking at getting in a stock that will have its work posted in scientific journals this year.  This will amount to tremendous exposure for the company and the stock.  Talk about getting in before the crowd.  In my view this isn't your run of the mill triple zero stock.  This one has actual staying power and I expect the stock to hold its gains from the upcoming bounce in advance of the scientific paper releases.  SCLL is going to get a lot more attention though out the year, and the stock will benefit from this.  

SCLL is currently trading right near its 52 week lows .  It should post gains of several hundred percent from here as investors begin to take notice of the inherent value, and the potential positive exposure that lies ahead.  I am setting a short term target of $.002, which is a price seen less than two months ago.  A break of that price target would put much more loftier goals in sight, but I will save that for another day.